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Background: Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) is a common disorder in the general
population but often underestimated and underdiagnosed.
Methods: This questionnaire-based study evaluated the overall level of knowledge about OSAHS among Italian
General Practitioners (GPs), who are frequently involved in the management of this complex disease. This represents
an interesting aspect, because GPs intercept many of the patients with OSAHS, in which C-PAP could be potentially
indicated. Randomly-selected GPs were provided with questionnaires, which were then returned anonymously.
Results: 80 questionnaires have been validated; the participants in the sample examined were represented by 43
females and 37 males; the average age of participants was 51 years. The general knowledge on OSAHS is overall
satisfactory among GPs; it is recognized by most of the GPs interviewed as pathology in constant increase, and
associated with predisposing factors such as obesity. High blood pressure is perceived as an independent
cardiovascular risk factor in patients with OSAHS, in line with the majority of international studies. The C-PAP has
been identified as the care gold standard in patients with OSAHS, despite the lack of patient compliance in relation
to this procedure, while polysomnography was found to be the main instrumental procedure used in the diagnostic
workup of OSAS. The pulmonologist and a multidisciplinary team have been identified as the specialist figures of
reference to which to direct the patient through the diagnostic workup. Respiratory therapists and nurses represent
the role of educator in the proper management of the C-PAP in the opinion of 62% of respondents, while only 34%
think that this role should be played by the GPs and/or other specialists.
Conclusions: In conclusion, this survey about the perception of OSAHS among GPs in Italy highlighted a satisfactory
overall knowledge of OSAHS and only few weak points.
Keywords: Obstructive Sleep Apnoea/ Hypopnoea Syndrome (OSAHS), General Practitioners (GPs), Polysomnography,
Mechanical ventilation with positive airway pressure (C-PAP)Background
OSAHS is a common disorder in the general population
but often underestimated and underdiagnosed [1]. The
definition of the Obstructive Sleep Apnoea/Hypopnoea
Syndrome (OSAHS) cannot be separated from an integra-
tion of clinical and instrumental data. Clinically, OSAHS
is characterized by excessive daytime sleepiness and/or* Correspondence: carlo.lombardi@poliambulanza.it
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unless otherwise stated.alterations to the performance day and night snoring;
from the pathophysiological point of view OSAHS is
characterized by the occurrence during sleep of repeated
episodes of partial or complete obstruction of the upper
airways that are associated with oxygen concentration
phasic reductions resulting in oxygen desaturation of
arterial hemoglobin [2]. There are different degrees of
obstruction of the upper airways that can determine the
different respiratory events: complete obstruction (ob-
structive sleep apnea) and partial obstructions (divided
into: hypopneas and Respiratory Effort Related Arousalral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 “Questionnaire distributed to the participating Italian general practitioners (GPs)”
1. What is the definition commonly used for OSAHS? A) Daytime sleepiness associated with irregular breathing at night
B) Episodes of paroxysmal dyspnea caused by obstruction of the
upper and lower respiratory tract
C) Obstructive Sleep apnea induced by gastroesophageal reflux
D) Obstructive Sleep Apnea induced by persistent rhinitis
characterized by nasal obstruction
E) Obstructive Sleep Apnea induced by nocturnal asthmatic attack












5. The number of OSAHS patients in recent years has been: A) Stationary
B) In growth
C) In reduction
D) Do not know
6. OSAHS episodes of apnea/hypopnea can be of type: A) Obstructive
B) Central
C) Mixed
D) All of the above
E) Restrictive
7. Is it true that obese people present a higher risk of developing OSAHS? A) Yes
B) No
C) Yes, but only women and children
D) Yes, but also normal weight individuals can be affected
8. What is the prevalence of OSAHS in the hypertensive patients? A) <5%
B) Between 10 and 20%
C) Between 20-40%
D) > 50%




C) I don’t know
10. Are you aware of the questionnaire referred to as “Epworth Sleepiness Scale”? A) Yes, I use it in my professional activity
B) Yes, but do not use it
C) No, I do not know
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Table 1 “Questionnaire distributed to the participating Italian general practitioners (GPs)” (Continued)
11. In the suspected diagnosis of OSAHS, what is the specialist that you












C) Communication with the specialist
D) Degree of belief of the patient




C) Determination of nocturnal oximetry in continuous
D) Polysomnography
E) EEG
F) ECG Holter with integrated pressure arterial Holter
14. What is the OSAHS treatment of choice? A) Nasal septum plastic intervention
B) Uvulopalatopharyngoplasty (UPPP)
C) Treatment with topical nasal steroids
D) Topical association therapy with bronchial Long Acting
Bronchodilators (LABAs) and steroids (iCSs)
E) Nocturnal Oxygen continuous
F) C-PAP
G) Intraoral Orthodontic Devices
H) Sleeping pharmacological agent (like benzodiazepines)
I) Psychological approach
L) Yoga




C) Lack of acceptance
16. Who primarily has the responsibility of educating and supporting the
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diagnosis of OSAHS, the duration of respiratory events of
each of the types described above shall not be less than
10 seconds and no more than 3 minutes. The relief of the
obstructive events are processed using polygraphic instru-
ments recording the activity of the subject during an entire
night’s sleep [3]. The registration of an average number of
complete obstructive respiratory events (apneas) and/orincomplete (hypopneas, RERA) per hour of sleep (RDI,
Respiratory Disorder Index), equal to or > 10, configure a
condition of OSAHS in adult subject. Several lines of evi-
dence have identified OSAHS as an independent risk factor
of secondary hypertension, such as obesity [4-6]. The treat-
ment of OSAHS includes procedures such as mechanical
ventilation with positive airway pressure (C-PAP), ortho-






A - Daytime sleepiness associated with nocturnal irregular breathing
B - Acute dyspnea induced by upper and lower airway ostruction
C - Obstructive Sleep Apnea induced by Gastroesophageal Reflux
D - Obstructive Sleep Apnea induced by persistent obstructive 
rhinitis
Figure 1 “What is the definition commonly used for OSAS? “
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obstructive apnea sleeping supine. Some studies have
shown that C-PAP improves daytime and nighttime blood
pressure in patients with moderate and severe OSAHS,
highlighting the importance of management and adherence
to C-PAP therapy, in particular to normalize the oxygen
concentration [7]. The present study evaluated the overall
level of knowledge about OSAHS among italian General
Practitioners (GPs), who are frequently involved in the
management of this complex disease. This represents an
interesting aspect, because GPs intercept many of the
patients with chronic illness [8], as OSAHS, in which
C-PAP could be potentially indicated.
Methods
The results of this study were obtained through the com-
pletion of an anonymous questionnaire, created “ad hoc”
and based on the guidelines and the current literature, by
a panel of experts composed by General Practitioners
(GPs) and Specialists (like Pneumologists, ENT specialists,
and Allergologists). It consists of 16 items (Table 1) and is
distributed to GPs to assess the level of knowledge of the





Figure 2 “Among your patients, how many have a diagnosis of OSAHQuestionnaires were e-mailed to GPs over the entire
territory of Brescia, a northern town of Italy, and had to
be returned anonymously. Only the fully completed ques-
tionnaires were considered for the descriptive statistics. 80
questionnaires have been validated. The participants in
the sample examined were represented by 43 females and
37 males; the age range of participants was : 34–65 years,
and the average age was 51 years. Written informed
consent was obtained for publication of this report.
Results
As a general result, a good knowledge of the definition of
OSAHS emerged from the results, with 67% of correct
answer to the corresponding question in the questionnaire
(Figure 1). An adequate level of knowledge is also found for
the epidemiological data (Figure 2). OSAHS has a preva-
lence of 4% in males and 2% in female subjects aged
between 30 and 60 years, 1% of preschool children and 11%
in those aged > 61 years. More than half of the participants
answered the question correctly on the prevalence of
OSAHS in men (52% correct answers) and female (59% of
correct answers). The prevalence of OSAHS among GPs
surveyed is found to be low (0–0.5%) in line with the
known under-diagnosis of OSAHS in the general popula-
tion. The incidence of OSAS in the general population is
11% and is in constant increase, as correctly perceived by
GPs participating in the study (54% of correct answers).
Instead, poor knowledge of the underlying pathophysio-
logical mechanisms seems to emerge, with only 46% of
respondents correctly answering to the question on apnea/
hypopnea in OSAHS). On the other side, most of the GPs
perceive the importance of the association between OSAHS
and obesity (71%) and between OSAHS and hypertension
(63% of respondents), although in the latter case, the true
prevalence is underestimated (Figure 3A). No GPs has
identified the true prevalence of hypertension, which is
around 50-60% in patients with a diagnosis of OSAHS.
OSAHS as an independent cardiovascular risk factor was
correctly identified by 84% of respondents (Figure 3B).
Currently the knowledge of the questionnaire “SleepinessA -No
B -between 0  and 5







6% A - < 5%
B - Between 10
and 20%







C - I dont' know
D - No Response
A -Prevalence of OSAHS in the 
hypertensive patients.
B -OSAHS as indipendent cardiovascular 
risk factor
Figure 3 “Answers to the question about the prevalence of OSAHS in hypertensive patients (3A) and about the perception of OSAHS
as an independent cardiovascular risk factor (3B)”.
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hood of falling asleep or dozing off in various situa-
tions, which is a useful metric to suspecting OSAHS.
78% of the GPs surveyed did not know about it, while
only 28% indicated to be aware but not to use it
(Figure 4A). 60% of the GPs identifies the pulmonolo-
gist as the main contact person in the diagnosis of the
OSAHS. 20% also identifies the need for a multidiscip-
linary team in the management of clinical and instru-
mental problem. The primary obstacles in accessing to
specialist care were found to be the long waiting times
(50%), the difficulty of convincing the patient (22%)
and the complex interaction with the specialist (16%)
(Figure 4B), emphasizing a lack of hospital-community
collaboration that is rather fundamental in the clinical
management of chronic disorders such as OSAS. 70%
of respondents showed a good expertise in the
diagnostic-therapeutic course of OSAHS, identifying in
the polysomnography (Figure 5A) and in the C-PAP
(Figure 5B) the diagnostic and therapeutic gold stan-
dards, respectively. 65% of GPs participating in the
study is, however, aware of the lack of acceptance of
the C-PAP by the patient, emphasizing the need for
adequately trained personnel in education to the pa-
tient for the proper functioning of the C-PAP. In the
62% the respiratory therapist and the nurse are the
healthcare providers who should compete primarily on
the role of educator, while only 39% identified the GP





A. Hepworth Sleepiness Scale 
degree of knowledge   
A - Yes, I use it
B - Yes, but i dont' use it
C - No
NA -No answer
Figure 4 GP's knowledge about the Hepworth questionnaire (A) and iDiscussion and conclusions
OSAHS is a common disorder in the general population
but often underestimated and underdiagnosed. OSAHS is
an independent risk factor for hypertension and cardio-
vascular disease and is the frequent underlying disease of
secondary hypertension and resistant hypertension [9].
Randomized, controlled trials have evaluated the use of
continuous positive airway pressure (CPAP) to reduce BP
among persons with OSA. The benefits of OSA treatment
are related to implications for hypertension management.
Several lines of evidence have also identified OSAHS as an
independent risk factor of secondary hypertension, such
as obesity. According to most studies, the treatment of
obstructive breathing disorders during sleep makes a
significant clinical improvement by reducing both blood
pressure nocturnal diurnal [10]. The pathophy-siological
mechanisms underlying this phenomenon are not yet clear.
However, several mechanisms have been proposed, includ-
ing increased sympathetic activity in response to hypoxemia
and hypercapnia resul-ting in the chemoreceptor activation
and increased peripheral vascular tone. Other processes
implycated include vasoconstrictors in the circulation,
humoral factors such as Endothelin-1 (ET-1) and endothe-
lial dysfunction [11,12]. Furthermore, patients with OSAHS
could be more easily predisposed to a weight gain. The sim-
ultaneous presence of obesity and OSAHS increases the
risk of hypertension. In this study, the point of view of GPs
showed a good knowledge of the OSAHS regarding the





B. Problems for access to specialist care 
A - Waiting time
B - Cost
C - Communication with
the specialist
D - Degree of belief of the
patient
NA -No Anwer
ssues in access to specialist care (B).
Figure 5 “OSAHS diagnostic (A) and therapeutic (B) Gold standard“.
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recognized by most of the GPs interviewed as disease in
constant increase, associated with predisposing factors such
as obesity, male sex, older age, use of hypnotics drugs and
bad life habits such as alcohol abuse and cigarette smoking.
High blood pressure is perceived as an independent cardio-
vascular risk factor in patients with OSAS, in line with
major international studies and highlighting the importance
of an appropriate treatment that can reduce blood pressure
in both daytime and nighttime in these patients. Instead,
the degree of knowledge of rating scales in the outpatients,
such as Epworth Sleepiness Scale, resulted insufficient. The
C-PAP has been identified as the gold standard of care in
patients with OSAS, despite the lack of patient compliance
in relation to this procedure, while polysomnography was
found to be the main test instrument used in the diagnostic
workup of OSAS. The pulmonologist and a multidisciplin-
ary team have been identified as the specialist figures of
reference to which to direct the patient through the
diagnostic workup of OSAS despite the waiting time, the
patient’s belief tiring and difficult interaction with the
specialist frequently represent the major barriers in acces-
sing to specialist care. Finally, respiratory therapists and
nurses represent the role of educator in the proper manage-
ment of the C-PAP in the opinion of 62% of respondents,
while only 34% think that this role should be played by the
GP and the specialist reference. Overall, it appears essential,
as well as in all chronic diseases in the growing number ofpatients with adult-age, a proper understanding of the
problem and an integrated hospital-community to guide
the patient with OSAS through the proper procedures and
best diagnostic and therapeutic able to prevent, or limit, the
complications of this disease [13,14]. The results of this
study would allow to take appropriate educational actions
and this questionnaire could be used to monitor the
possible effects of divulgation and educational initiatives
over time.
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